Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
N-Tallow-1,3-propylenediamine, For The Manufactu...
Certificate Number : R1-CEP 2001-017 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2006-04-18
Type : TSE
Substance Number :
88
PharmaCompass offers a list of CAS 62063-19-8 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CAS 62063-19-8 manufacturer or CAS 62063-19-8 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CAS 62063-19-8 manufacturer or CAS 62063-19-8 supplier.
PharmaCompass also assists you with knowing the CAS 62063-19-8 API Price utilized in the formulation of products. CAS 62063-19-8 API Price is not always fixed or binding as the CAS 62063-19-8 Price is obtained through a variety of data sources. The CAS 62063-19-8 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CAS 62063-19-8 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS 62063-19-8, including repackagers and relabelers. The FDA regulates CAS 62063-19-8 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS 62063-19-8 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CAS 62063-19-8 supplier is an individual or a company that provides CAS 62063-19-8 active pharmaceutical ingredient (API) or CAS 62063-19-8 finished formulations upon request. The CAS 62063-19-8 suppliers may include CAS 62063-19-8 API manufacturers, exporters, distributors and traders.
A CAS 62063-19-8 CEP of the European Pharmacopoeia monograph is often referred to as a CAS 62063-19-8 Certificate of Suitability (COS). The purpose of a CAS 62063-19-8 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CAS 62063-19-8 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CAS 62063-19-8 to their clients by showing that a CAS 62063-19-8 CEP has been issued for it. The manufacturer submits a CAS 62063-19-8 CEP (COS) as part of the market authorization procedure, and it takes on the role of a CAS 62063-19-8 CEP holder for the record. Additionally, the data presented in the CAS 62063-19-8 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CAS 62063-19-8 DMF.
A CAS 62063-19-8 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CAS 62063-19-8 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CAS 62063-19-8 suppliers with CEP (COS) on PharmaCompass.
